Objectives: Autologous mesenchymal stem cell transplantation has been shown to improve myocardial function in ischaemic cardiomyopathy. We studied one hypothetical mechanism, neo-angiogenesis, using allogeneic mesenchymal stem cell transplantation in an ischaemic swine model. Methods: Allogeneic mesenchymal stem cells were injected in the peri-infarct area (1 Â 10 6 cells kg À1 ) 2 weeks after myocardial infarction. Myocardial infarction alone (n = 3) served as a control group. In the myocardial infarction-mesenchymal stem cells group (n = 6), tacrolimus was given from day 0 to day 12. Capillary density and inflammatory/rejection processes (anti-factor VIII and anti-CD3/CD68 monoclonal antibodies, respectively) were compared between groups. Results: In scarred myocardium, capillary density was similar between both ischaemic groups: 15.4 (AE15.3) and 14.7 (AE15.2) vessel/field in myocardial infarction-mesenchymal stem cells and myocardial infarctionalone groups (non-significant). In viable myocardium adjacent to the infarction, capillary density was significantly increased in the myocardial infarction-mesenchymal stem cells group than in the myocardial infarction-alone group ( p = 0.002). The number of infiltrating CD3+ cells was equivalent in both myocardial infarction-alone and myocardial infarction-mesenchymal stem cells groups (CD3+: 8.6% vs 9.3%, non-significant). However, CD68+ cell infiltration was more prominent after mesenchymal stem cell transplantation (4.7% vs 2% in myocardial infarction alone, p < 0.01). Conclusions: Allogeneic mesenchymal stem cell transplantation enhances angiogenesis after myocardial infarction. This effect is limited to the viable myocardium. Using a concomitant 12-day course of tacrolimus, no mesenchymal stem cell-specific cellular immune response was demonstrated. #
Introduction
The proof of principle that bone marrow progenitor cells could participate in neo-angiogenesis after an ischaemic insult was first described by Asahara et al. in a transgenic bone marrow reconstituted mouse model [1] . Over the past years, the potential angiogenic properties of adult stem cells have been extensively studied in the context of ischaemic cardiomyopathy [1] [2] [3] . Most of those animal studies have used autologous or isogenic stem cells for transplantation purposes and showed improvement in myocardial function.
The exact mechanisms by which mesenchymal stem cells (MSCs) improve myocardial function are still a matter of debate, and both direct [4] and indirect [5] effects have been suggested. Among the indirect (paracrine) effects, increased local neo-angiogenesis has been shown to correlate with improved myocardial function [6, 7] .
For clinical human application, a potential limitation of autologous MSC transplantation is the time required to select and expend the appropriate cells. Furthermore, functionality of precursor cells has been questioned in patients with cardiovascular risk factors [8] . One way to circumvent these limitations could be to use allogeneic MSCs.
However, studies performed in vivo in rodents have shown that allogeneic MSCs can elicit a primary immune response in both immunocompetent and moderately immunosuppressed animals [9, 10] .
Similarly, in swines, two independent groups have recently demonstrated that intracardiac (or subcutaneous) allogeneic MSCs (or umbilical cord stem cells) were able to trigger an alloimmune response [11, 12] , resulting in cytotoxic alloantibody production and decreased survival of MSC donor-matched skin grafts [11] .
Based on our previous work on tolerance after allogeneic full organ transplantation [13] as well as on our most recent experimental work demonstrating that with a moderate transient immunosuppression, the primary immune response to allogeneic MSC transplantation could be overcome [14] , we decided to use in the present study a 12-day course of tacrolimus.
Aims of this study were twofold: first to determine whether intracardiac allogeneic MSC transplantation would enhance neo-angiogenesis after myocardial infarction using a large animal model that shares with humans a terminal coronary circulation, and, second, to investigate the inflammatory response to allogeneic MSC transplantation at the myocardial level in the presence or absence of transient immunosuppression.
Materials and methods

2.1.
In vitro studies 2.1.1. Mesenchymal stem cell isolation, culture and cell surface phenotype flow cytometry MSC isolation and culture conditions were described earlier [12] . Bone marrow mesenchymal stem cells were stained with monoclonal antibodies conjugated with fluorescein isothiocyanate (FITC) or phycoerythrin (PE): CD31-PE (Acris GmbH, Ge), CD29-FITC, CD44-FITC, CD45-FITC, CD45RA-FITC, CD90-PE (BD Biosciences, Erembodegem, Belgium) and CTLA4-Ig-FITC (Ancell, Bayport, MN, USA) and for CD14 (Serotec, Kidlington, UK) and CD 117 (kindly provided to us by Dr D. Sachs, TBRC, Boston, MA, USA). Cells were also stained with CD2-FITC (MSA-4), CD4-FITC (74-12-4), CD8-Biotin (76-2-11, revealed with streptavidin-phycoerythrin conjugate (BD Pharmingen)), Swine Leucocyte Antigen (SLA) -Class I (7-34-I-FITC), SLA -Class II (ISCR-3-FITC). (All primary antibodies from Laboratory of Experimental Immunology, Université Catholique de Louvain, Brussels, Belgium.) At least 15 000 events were analysed by flow cytometry (FACScan, BD Biosciences) with the CELLQUEST software.
In vivo studies
Experimental animals
Anaesthesia was induced by intramuscular injection of tiletamine and zolazepam (Zoletil W , Virbac, Carros, France). Intravenous access was established through an ear vein. After tracheal intubation, inhalation anaesthesia was maintained by enflurane (0-1.5%), nitrous oxide and oxygen. Electrocardiogram and respiration were monitored by a multiplechannel recorder (Portal Systems Inc., Beaverton, OR, USA).
Nine animals were used in this study. In the first group, following median sternotomy, a myocardial infarction was created (myocardial infarction (MI)-alone, n = 3). In our second group, 2 weeks after myocardial infarction, allogeneic MSCs were transplanted (MI-MSC Tx, n = 6).
For both the AMI-alone group and the MI-MSC transplantation group, the left anterior descending (LAD) was ligated, and the pericardial sac and sternum were closed.
All swines received atenolol (50 mg orally) prophylactically. The animals were allowed to recover under monitoring for the next 4 h. Antibiotics (cefazolin, 35 mg kg À1 IM) and analgesics (buprenorphine, 0.03 mg kg À1 IM) were administered shortly after surgery.
In the MI-MSC transplantation group, 2 weeks after infarction, after repeat sternotomy, allogeneic MSCs (10-40 Â 10 6 cells) were injected directly in the peri-infarct area, using a 27-gauge needle (Fig. 1) .
Prior to transplantation, cultured MSCs were washed three times in phosphate-buffered saline (PBS). Before injection, MSC viability was assessed using trypan blue staining.
Animals were euthanised either 1 month after index procedure (in the MI-alone groups) or 4 weeks after MSC transplantation.
Immunosuppression
In the MI-alone group, no immunosuppression was given. Animals in the MI-MSC group received a 12-day course of tacrolimus (Fujisawa Pharmaceutical GmbH, Munich, Germany), given intravenously (0.1 mg kg À1 ) on day 1 and orally (1.33 mg kg À1 day À1 ) from day 2 onwards, adjusting to maintain blood levels between 7 and 20 ng ml À1 . Whole blood levels were determined by microparticle enzymelinked immunoassay (IMX Tacrolimus II; Abbott Laboratories, Abbott Park, IL, USA).
Histologic analysis
After heart explantation, tissues were immediately fixed overnight in formalin and embedded in paraffin. Serial sections (5-mm thick) were mounted on glass slides with demineralised water and dried for 12 h at 37 8C. Samples were obtained from both the infarct zone and the neighbouring viable myocardium.
Angiogenesis and myocardial micro-vessel density
For each group, we processed sections by immunohistochemical detection using a mAb against factor VIII and haematoxylin-eosin staining, respectively, as described previously [15] . For each animal, five paraffin-embedded 5-mm sections, at least 20 mm apart, were selected from the tissue block available. For each section, our goal was to select six visual fields where a cross section of capillaries was clearly visible. They were randomly selected in the infarct zone (IZ) and in the adjacent viable myocardium or remote zone (RZ), and the number of capillaries was counted under Â100 magnification. A countable vessel was defined as any factor VIIIpositive endothelial cell or endothelial cell cluster separate from adjacent micro-vessels or connective tissue elements. There was no cut-off for vessel calibre.
Vessels for which a layer of smooth muscle cells was clearly identified were not included in the measurements. The entire myocardium was classified as belonging to distinct strata of myocardium: sub-endocardium, intermediate myocardium and sub-epicardium.
Inflammatory response assessment
To assess immune responses to intracardiac MSC transplantation, we selected additional sections from the MI-alone group and the MI-MSC group and processed sections by immunohistochemical detection for CD3 cells (lymphocytes) and CD68 cells (macrophages) using specific mAb (anti-CD3; titre 1:250; NeoMarkers Inc., CA, USA, and anti-CD68, titre 1:800; Clone MAC387, Abcam PLC, Cambridge, UK).
Ten non-overlapping areas per slide were studied. An original 50Â magnification with a grid of 210 mm Â 210 mm was used to quantify cellular infiltration.
All histomorphometric studies (factor VIII studies and cellular infiltration studies) were performed by independent observers (A.L.H.-D.H.) blinded to treatment assignment and were done with an image analyser KS-400 (Carl Zeiss Imaging Solutions GmbH, München, Germany). All sections used for these quantifications were processed simultaneously. Results are given as mean AE standard deviation (SD).
Animal care
All works were approved by the Catholic University of Louvain School of Medicine Animal Care and Ethical Committee and performed according to the guidelines outlined in the Guide for the Care and Use of Laboratory Animals published by the National Institutes of Health (NIH publication 86-23, revised 1996).
Statistical analysis 2.5.1. Numeration of the vessels
When grouping the counts separately for each study and for each area, we found subsets of data having variances approximately equal to the sum of the mean and the square of the mean: so the results were modelled by a negative binomial distribution (discrete gamma-Poisson distribution).
Data of a negative binomial distribution may be studied by a generalised linear model. The link function of negative binomial distribution for a linear regression is
X being the vector of independent variables, b the vector of the coefficients to be evaluated and m the dependent variable with a negative binomial distribution.
The model matching with our data use a gamma distribution with r = I; this is an exponential distribution.
Each animal was studied by several samplings, and the results were correlated for the same animal: so linear regression was studied by generalised estimating equation (GEE). Quasi-least squares (QLS) is convenient to compute the internal correlation to adjust the regression for a GEE [16] .
We selected a model with a common internal correlation for all the animals. The validity of the model was checked by the dispersion around the QLS linear regression: the compatibility with the expected value I was studied by chi-square test.
Percentage of cells
The percentages were studied by a logistic QLS linear regression with overdispersion. We chose a model with a common internal correlation for all the animals.
Significance
Significance for multiple comparisons was adjusted according to the Holm's sequentially rejective Bonferroni procedure [17] .
An adjusted p smaller than 0.05 was considered as significant.
Results
Analysis of MSC surface markers of long-term culture swine MSCs
As shown in Fig. 2 , long-term culture swine MSC were negative for haematopoietic stem cell (HSC) lineage markers such as CD-34, CD-45 and CD-117. They did not express CD-31 or CD-14. They were strongly positive for MSC markers such as CD-90, CD-29 and CD-44. Under an unstimulated culture condition, they express low levels of SLA Class I molecules and do not express either SLA Class II or CD80/CD86 molecules (data not shown).
In swine, unfortunately, recently identified MSC markers such as CD105, VCAM-1, STRO-1 and bone morphogenic protein receptors (BMPRs) could not be ascertained since commercially available antibodies are lacking.
Pattern of capillary density according to the different strata of the ventricular wall and effect of ischaemic injury
As shown in Table 1 , compared with naïve myocardium, acute myocardial infarction triggered an enhanced neoangiogenesis in all three strata studied (sub-endocardium, intermediate myocardium and sub-epicardium) ( p < 0.05 for each). This response was mostly independent of transplantation of MSC, since inter-group differences between MI-alone and MI-MSC were not statistically significant in the subepicardium (15.5 W 11.9 vs 18.3 W 13.1 vessel/field, p = 0.69) nor at the level of the mid-myocardium (11.7 W 17.6 vs 13.3 W 13.1 vessel/field, p = 1.0).
Distinct pattern of neo-angiogenesis according to the functionality of the ventricular wall after myocardial infarction
For both the MI-alone and MI-MSC groups, we analysed the two distinct areas of the infarcted ventricular wall with regard to neo-angiogenesis: the infarct zone (IZ) (scarred fibrotic and area with patchy scar/scattered cells) and the borderline zone with viable muscle (remote zone or RZ) which appeared on histology as normal bundles of myocytes with minimal fibrosis (Fig. 3A-D) . Of note, in our model, this particular area was the targeted area for MSC transplantation. Table 2 summarises the set of data available from all study animals used for analysis after initial tissue quality assessment.
In the MI-alone group, the mean number of vessel per field was 2.7 (95% confidence interval (CI): 1.6-6.6) and 14.5 (95% CI: 10.4-23.2) in the remote zone and infarct zone, respectively ( p = 0.005). In the MI-MSC group, the mean number of vessels per field in the remote zone was 10.7 (95% CI: 8.1-15.6) and was 16.5 (95% CI: 13.2-21.9) in the infarct zone, respectively ( p = 0.37). Inter-group differences were statistically significant when we compared to the remote zone ( p = 0.04) but not in the infarct zone ( p = 0.85) ( Table 3) . One month after infarction with/without MSC transplantation, the percentage of infiltrating CD3 (+) T cells in the infarct zone and neighbouring myocardium was of the same magnitude regardless of whether an infarction alone was created (mean = 8.6% (95% CI: 7.1-10.3)) or allogeneic MSCs injected 2 weeks after infarction (mean = 9.3% (95% CI: 7.9-11.0)) ( p = NS). However, significant differences were found in the analysis of CD68 (+) intracardiac macrophages, with a twofold increase in cellular infiltration in the MSC group (mean = 4.7% (95% CI: 3.3-6.5)) than in the AMI-alone group (mean = 2% (95% CI: 1.1-3.6)) ( p = 0.012), suggesting that transient immunosuppression had no impact on the innate immune/inflammatory reaction which took place after allogeneic cellular transplantation (Fig. 5) .
Discussion
This study in swine corroborates previous studies showing that MSC transplantation improves locoregional angiogenesis in ischaemic cardiomyopathy models [1, 2, 18, 19] . However, the original aspect of this study is that the angiogenic effect was obtained using allogeneic MSCs transplanted in fully immunocompetent swine that only received transient immunosuppression. Indeed, in most of the previously published studies, either human MSCs were transplanted into immunodeficient mice or rats [2, 19] or autologous/ isogenic MSCs were used [1, 18] .
In 2005, Silva et al. demonstrated in a dog chronic ischaemia model that allogeneic MSC transplantation enhanced vascular density and that donor MSCs were colocalised with endothelial cells mostly in the ischaemic zones [6] . Of note, no myocyte transdifferentiation was noticed.
However, recently, the angiogenic hypothesis was challenged by conflicting reports coming both from the laboratory [20] and from a well-conducted randomised clinical trial [21] . In their swine model of acute myocardial infarction, with allogeneic MSCs transplanted on day 3 without immunosuppression, Hashemi et al. were not able to show a significant enhancement of angiogenesis neither in the infarcted area nor in the borderline zone, although MSC transplantation did significantly decrease the infarct size. In their landmark clinical study, combining tissue Doppler analysis and positron emission tomography-2-deoxy-2-(18F)-fluoro-o-glucose (PET-FDG) scanning, Janssens et al. did not find blood flow enhancement in the autologous bone marrow-derived mononuclear cell-transplanted group.
Our overall assessment of neo-angiogenesis failed to demonstrate that allogeneic MSC transplantation per se significantly enhances capillary density and, as such, confirmed the recent study by Hashemi et al. [20] . Comparing the two studies is difficult since different doses of MSCs were injected and the timing of transplantation was different. Of note, although not statistically significant, these authors noticed a 20% increase in capillary density throughout all their MSC groups.
An in-depth analysis of our histomorphometric studies revealed that our anti-factor VIII slides data set included more that 70% of area representing fibrotic or poorly cellularised zones of myocardium whereas the zone of fully viable myocardium represented the remaining 30% of the slides data set. In the sub-analysis of the viable myocardium, we found at least a threefold increase in capillary density compared with the MI-alone group, a finding similar to the 2.3-fold increase described by Yoon et al. [2] as well as other studies that assessed capillary density in the 'border zone' areas [1, 18, 19] . Another interesting finding from this study is the minimal innate and adaptative alloimmune cellular response shown to occur after allogeneic MSC transplantation in the sub-acute phase of myocardial infarction when transient immunosuppression is provided concomitantly.
To date, few in vivo studies have specifically addressed the immune response to allogeneic MSC transplantation. Imanishi et al. [22] demonstrated in an acute myocardial infarction model that on day 1, mostly macrophages were found at the site of transplantation, whereas by day 28, neither MSC nor inflammation was present. Evidently, concomitant myocyte death might have been a confounding factor. When injected in rodent brain, allogeneic MSCs are rejected, and after 14 days, the inflammatory response was prominent whereas few CD8 T cells were found [23] . Similar findings were reported after intracardiac injection when analysed at 4 weeks [10] .
Finally, Eliopoulos et al. described an increased CD8 and NK/NKT cells infiltration of the epo + MSC constructs 2 weeks after subcutaneous implantation and an acquired refractoriness to allogeneic MSC transplantation secondary to immunisation [24] .
We found that a similar proportion of CD3 T cells was present in both AMI-alone and MSC Tx groups, suggesting either that allogeneic MSC were not truly immunogenic or underlying the efficiency of the immunosuppressive treatment. The latter being more likely since we have previously shown that intracardiac allogeneic MSCs injected without immunosuppression triggers a sustained T-and B-cell donorspecific immune response [12] . However, we found a significant increase of macrophage infiltration after allogeneic MSC transplantation, the first triggered cell from the innate immunity. In contrast to Ashemi et al., who reported, in a similar model, massive cellular infiltration up to 12 weeks after allogeneic MSC injection (in 77% of their swine) in the absence of immunosuppression [20] , we did not observe any cluster of inflammatory cells in our histomorphometric studies. Whether this innate response is truly an alloimmune response or a classical inflammatory phenomenon secondary to death/apoptosis of transplanted cells remains an unanswered question.
Obviously, our study suffers several limitations. The first is the absence of longitudinal cell survival tracking as we know from previous studies that most of the transplanted cells failed long-term engraftment [25] . Secondly, the study did not assess the respective contribution of donor and host stem cells to the angiogenic process. We can thus only speculate, as it has been recently demonstrated by Cho et al., that donor MSCs are responsible for a first critical step in the repair through cellular cross-talk mechanisms, thereby upregulating a battery of recipient-cells-derived cytokines such as stromal derived factor-1 (SDF-1), fibroblast growth factor-2 (FGF-2), hepatocyte growth factor (HGF) and insulin growth factor-I (IGF-I), the effects of which (stem cell recruitment, anti-apoptotic effect) will then survive the progressive attrition of the transplanted cells [3] . Thirdly, this experimental design of acute myocardial infarction on normal myocardium does not fully reproduce the clinical scenario of chronic ischaemic cardiomyopathy and all its progressive compensatory mechanisms.
In conclusion, this study demonstrates that allogeneic MSC transplantation enhances angiogenesis after myocardial infarction in a relevant large animal model. This effect is located in viable area of myocardium and not to the fibrotic zone. Providing the concomitant use of a short course of immunosuppression, no MSC-related specific cellular alloimmune response was demonstrated at the site of transplantation.
